Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion (FISIOPLEURA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02359383|
Recruitment Status : Recruiting
First Posted : February 10, 2015
Last Update Posted : September 20, 2018
|Condition or disease||Intervention/treatment||Phase|
|Pleural Diseases Infection||Other: Chest physiotherapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||22 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion|
|Study Start Date :||January 2014|
|Estimated Primary Completion Date :||November 2019|
|Estimated Study Completion Date :||January 2020|
Active Comparator: Chest Physiotherapy group
Conventional medical treatment plus Chest Physiotherapy
Other: Chest physiotherapy
Depending on the location of the pleural effusion different techniques are performed: 1. Postural control techniques; 2. Secretions drainage techniques; 3. Thoracic expansion techniques; 4. Diaphragmatic mobility techniques.
No Intervention: Control grup
Conventional medical treatment
- Change in improving lung function [ Time Frame: 3 months ]To determine if Respiratory Physiotherapy (RP) associated with conventional medical treatment (CT) improves functional sequelae secondary to infectious pleural effusion. All patients will performed spirometric studies at the beginning of the study, at 3 and 6 month.
- Change in resolution of pleural effusion [ Time Frame: 3 months ]To analysed if CP allows faster resolution of pleural effusion. A simple thoracic Rx will be performed to assess radiological changes every month till resolution of pleural sequelae.
- Reduce hospital stay [ Time Frame: 3 months ]To assess if CP added to medical therapy in patients with infectious pleural effusion decreased hospital stay
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02359383
|Contact: Inmaculada Castillo||+348425000 ext email@example.com|
|Granollers, Barcelona, Spain, 08401|
|Contact: Inmaculada Castillo +348425000 ext 2675 firstname.lastname@example.org|
|Principal Investigator:||Inmaculada Castillo||Hospital General de Granollers|